Innovotech Inc. is a pioneering company specializing in the development of biofilm products, aimed at offering innovative solutions for medical, agricultural, and industrial challenges caused by microbial biofilms. Biofilms, which are organized communities of microorganisms, are the culprits behind various diseases in human health, animal health, and agriculture. The company boasts a diverse product line addressing biofilm issues across multiple industries. Its offerings include the MBEC Assay™, bioFILM PA™, and InnovoSCEPT veterinary kits. Notably, the MBEC Assay™, a high throughput biofilm growth device, has gained approval as an ASTM International standard. Additionally, bioFILM PA™ represents the first diagnostic kit assisting physicians in selecting the most effective combination antibiotic treatment for patients with biofilm-based chronic lung infections. Meanwhile, the InnovoSCEPT veterinary kits are tailored to determine the most effective antibiotic treatment for infections in both large and small animals. Innovotech has also been actively developing two advanced-stage products. Agress® stands out as a unique, environmentally friendly seed treatment and plant spray designed to safeguard crops against bacterial and fungal infections. On the other hand, Sani-Lux™ is a light-activated, natural hard surface sanitizer. Established in 2001 and headquartered in Canada, Innovotech recently received a $154.00K grant investment on 17 December 2020, with the backing of Agriculture and Agri-Food Canada. As the company continues to make strides in the biotechnology and healthcare industries, its commitment to combating biofilm-related challenges positions it as a noteworthy prospect for venture capital consideration.
No recent news or press coverage available for Innovotech Inc..